Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Anthim (obiltoxaximab) Injection for the Treatment of Inhalational Anthrax

Drug (Brand / Generic)

Anthim (obiltoxaximab)

Company

Elusys Therapeutics

Therapy Class

Monoclonal antibody

Current Indication

Inhalational anthrax

Market Sector

Anti-infective

Development Status

Approved in the US
Expand

Go Top